• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Concentra Group Holdings Parent Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    5/7/26 4:46:25 PM ET
    $CON
    Medical Specialities
    Health Care
    Get the next $CON alert in real time by email
    cghp-20260505
    FALSE000201459600020145962026-05-052026-05-05

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    _______________
    FORM 8-K
    _______________

    CURRENT REPORT
    Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

    Date of Report (Date of Earliest Event Reported): May 5, 2026
    _______________
    CONCENTRA GROUP HOLDINGS PARENT, INC.

    (Exact Name of Registrant as Specified in Its Charter)
    _______________

    001-42188
    (Commission File Number)
    Delaware
    30-1006613
    (State or Other Jurisdiction of Incorporation)
    (I.R.S. Employer Identification No.)

    5080 Spectrum Drive, Suite 1200W
    Addison, TX, 75001
    (Address of principal executive offices) (Zip code)

    (972) 364-8000
    (Registrant’s telephone number, including area code)

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

    Title of each class
     
    Trading
    Symbol(s)
     
    Name of each exchange on which registered
    Common Stock, $0.01 par value per share
     
    CON
     
    New York Stock Exchange
     
     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter):




    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐





    Item 2.02 Results of Operations and Financial Condition.
    On May 7, 2026, Concentra Group Holdings Parent, Inc. (the “Company”) issued a press release announcing its financial results for its first quarter ended March 31, 2026. A copy of the press release and financial schedules are attached as Exhibit 99.1 to this report and incorporated herein by reference.
    The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 2.02 and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act.
    Item 7.01 Regulation FD Disclosure.
    Attached as Exhibit 99.2 and furnished for purposes of Regulation FD is a presentation published by the Company on May 7, 2026, in connection with its press release announcing its financial results for its first quarter ended March 31, 2026.
    The information in this Current Report on Form 8-K (including Exhibit 99.2) is being furnished solely to satisfy the requirements of Regulation FD and shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act or the Exchange Act.
    Item 8.01 Other Events.
    Dividend Declaration
    On May 5, 2026, the Board of Directors declared a cash dividend of $0.0625 per share. The dividend will be payable on or about June 9, 2026, to stockholders of record as of the close of business on May 19, 2026.
    Item 9.01 Financial Statements and Exhibits.
    (d) Exhibits.
    Exhibit Number
    Description
    99.1
    Press Release, dated May 7, 2026, announcing financial results for the first quarter ended March 31, 2026 and cash dividend.
    99.2
    Concentra Group Holdings Parent Inc. Presentation.
    104
    Cover Page Interactive Data File (embedded within the Inline XBRL document).



    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    CONCENTRA GROUP HOLDINGS PARENT, INC.
    Date: May 7, 2026
    By:
    /s/ Timothy Ryan
    Timothy Ryan
    Executive Vice President and Chief Legal Counsel




    Get the next $CON alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CON

    DatePrice TargetRatingAnalyst
    7/1/2026Outperform
    William Blair
    6/5/2026$30.00Buy
    Goldman
    9/18/2025$31.00Overweight
    Analyst
    12/16/2024$24.00Neutral → Buy
    BofA Securities
    10/7/2024$30.50 → $24.00Buy → Neutral
    BofA Securities
    8/20/2024$33.00Outperform
    RBC Capital Mkts
    8/19/2024Buy
    BofA Securities
    8/19/2024$29.00Buy
    Deutsche Bank
    More analyst ratings

    $CON
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    William Blair initiated coverage on Concentra

    William Blair initiated coverage of Concentra with a rating of Outperform

    7/1/26 8:29:15 AM ET
    $CON
    Medical Specialities
    Health Care

    Goldman initiated coverage on Concentra with a new price target

    Goldman initiated coverage of Concentra with a rating of Buy and set a new price target of $30.00

    6/5/26 8:26:54 AM ET
    $CON
    Medical Specialities
    Health Care

    Analyst resumed coverage on Concentra with a new price target

    Analyst resumed coverage of Concentra with a rating of Overweight and set a new price target of $31.00

    9/18/25 8:38:55 AM ET
    $CON
    Medical Specialities
    Health Care

    $CON
    SEC Filings

    View All

    Concentra Group Holdings Parent Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Concentra Group Holdings Parent, Inc. (0002014596) (Filer)

    7/10/26 4:53:08 PM ET
    $CON
    Medical Specialities
    Health Care

    SEC Form 144 filed by Concentra Group Holdings Parent Inc.

    144 - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)

    7/1/26 4:45:24 PM ET
    $CON
    Medical Specialities
    Health Care

    SEC Form 144 filed by Concentra Group Holdings Parent Inc.

    144 - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)

    6/30/26 4:19:00 PM ET
    $CON
    Medical Specialities
    Health Care

    $CON
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ortenzio Robert A sold $3,964,597 worth of shares (130,000 units at $30.50) (SEC Form 4)

    4 - Concentra Group Holdings Parent, Inc. (0002014596) (Issuer)

    7/6/26 4:05:50 PM ET
    $CON
    Medical Specialities
    Health Care

    Director Ortenzio Robert A sold $3,250,026 worth of shares (130,000 units at $25.00) (SEC Form 4)

    4 - Concentra Group Holdings Parent, Inc. (0002014596) (Issuer)

    6/2/26 4:29:52 PM ET
    $CON
    Medical Specialities
    Health Care

    Director Ortenzio Robert A sold $3,250,000 worth of shares (130,000 units at $25.00) (SEC Form 4)

    4 - Concentra Group Holdings Parent, Inc. (0002014596) (Issuer)

    5/11/26 5:01:25 PM ET
    $CON
    Medical Specialities
    Health Care

    $CON
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Concentra Expands into Idaho with Opening of Boise Medical Center

    Investment in Boise reflects Idaho’s continued growth and increasing demand for workforce health services Concentra® (NYSE:CON), the nation's leader in occupational and workforce health services, today announced the opening of its first Idaho medical center, expanding access to workforce health solutions for employers and employees throughout the Boise region. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260717723429/en/Concentra's new Boise medical center will officially open with a ribbon-cutting ceremony on July 22, expanding access to occupational health services for employers and employees across the Treasure Valley. Th

    7/20/26 10:30:00 AM ET
    $CON
    Medical Specialities
    Health Care

    Concentra Expands Near Kansas City International Airport with New Medical Center

    New medical center near Kansas City International Airport strengthens workforce health resources for the region’s growing business and transportation hub Concentra (NYSE:CON), the nation's largest provider of occupational health services, today announced the opening of a new medical center in Kansas City, Missouri, further expanding access to specialized workforce health services in one of the Midwest's most dynamic business and transportation hubs. Located at 10304 NW Prairie View Road, Kansas City, Missouri 64153, Concentra Kansas City Airport will provide a comprehensive suite of occupational health services designed to help employers maintain healthy, productive workforces while sup

    7/13/26 9:00:00 AM ET
    $CON
    Medical Specialities
    Health Care

    Concentra to Announce Second Quarter 2026 Results on Thursday, August 6, 2026

    Concentra® Group Holdings Parent, Inc. ("Concentra") (NYSE:CON) will release the financial results for its second quarter ended June 30, 2026, on Thursday, August 6, 2026, after the market closes. Concentra will host a conference call regarding its financial results on Friday, August 7, 2026, at 9 a.m. Eastern Time. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via Concentra’s website at https://ir.concentra.com. A replay of the webcast will be available shortly after the call at the same locations. Participants may join the audio-only version of the webcast or participate in the question-and-answer session by calling: Toll Free:

    7/9/26 4:00:00 PM ET
    $CON
    Medical Specialities
    Health Care

    $CON
    Financials

    Live finance-specific insights

    View All

    Concentra to Announce Second Quarter 2026 Results on Thursday, August 6, 2026

    Concentra® Group Holdings Parent, Inc. ("Concentra") (NYSE:CON) will release the financial results for its second quarter ended June 30, 2026, on Thursday, August 6, 2026, after the market closes. Concentra will host a conference call regarding its financial results on Friday, August 7, 2026, at 9 a.m. Eastern Time. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via Concentra’s website at https://ir.concentra.com. A replay of the webcast will be available shortly after the call at the same locations. Participants may join the audio-only version of the webcast or participate in the question-and-answer session by calling: Toll Free:

    7/9/26 4:00:00 PM ET
    $CON
    Medical Specialities
    Health Care

    Concentra Group Holdings Parent, Inc. Announces Results for Its First Quarter Ended March 31, 2026, Cash Dividend, and Raised FY 2026 Guidance

    Concentra Group Holdings Parent, Inc. ("Concentra," the "Company," "we," "us," or "our") (NYSE:CON), the nation's largest provider of occupational health services by number of locations, today announced results for its first quarter ended March 31, 2026, the declaration of a cash dividend, and raised guidance for full year 2026. "Our strong start to 2026 is a testament to the trust our clients place in us to care for their most valuable asset: their people," said Keith Newton, Chief Executive Officer of Concentra. "The meaningful growth in visit volumes we saw this quarter demonstrates that our clinical model and value proposition continue to lead in workers' compensation. Building on our

    5/7/26 4:30:00 PM ET
    $CON
    Medical Specialities
    Health Care

    Concentra to Announce First Quarter 2026 Results on Thursday, May 7, 2026

    Concentra® Group Holdings Parent, Inc. ("Concentra") (NYSE:CON) will release the financial results for its first quarter ended March 31, 2026, on Thursday, May 7, 2026, after the market closes. Concentra will host a conference call regarding its financial results on Friday, May 8, 2026, at 9 a.m. Eastern Time. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via Concentra's website at https://ir.concentra.com. A replay of the webcast will be available shortly after the call at the same locations. Participants may join the audio-only version of the webcast or participate in the question-and-answer session by calling: Toll Free: 888-5

    4/9/26 4:30:00 PM ET
    $CON
    Medical Specialities
    Health Care

    $CON
    Leadership Updates

    Live Leadership Updates

    View All

    Concentra Appoints Jason Cooper as Chief Data, Analytics, and Artificial Intelligence Officer

    Concentra®, (NYSE:CON) the nation's largest provider of occupational health services, today announced the appointment of Jason Cooper as Chief Data, Analytics, and Artificial Intelligence Officer. In this role, he will ensure Concentra's data strategy and governance, technology enablement, and insight generation are aligned with enterprise growth priorities. "Selecting Jason as our Chief Data, Analytics, and Artificial Intelligence Officer represents the natural progression of Concentra's established foundation in data, technology, and innovation," said Keith Newton, Chief Executive Officer of Concentra. "His expertise and extensive experience will enable us to continue to operationalize

    11/10/25 4:30:00 PM ET
    $CON
    Medical Specialities
    Health Care

    Concentra Announces the Appointment Of Vipin Gopal and Brigid Bonner To Its Board Of Directors

    Concentra® Group Holdings Parent, Inc. ("Concentra") (NYSE:CON), today announced the appointment of Vipin Gopal and Brigid Bonner to the Concentra Board of Directors, marking a strategic milestone for the occupational health services company. "We are pleased to welcome Vipin Gopal and Brigid Bonner to the Concentra Board," said Bob Ortenzio, Concentra's board chair. "As Concentra navigates growth and the opportunity to increase shareholder value, expanding the Board with two prominent health care leaders with data, technology, and business transformation expertise will prove to be a mobilizing force for the company." Vipin Gopal, PhD, brings over 25 years of experience successfully lead

    6/26/25 4:30:00 PM ET
    $CON
    Medical Specialities
    Health Care

    Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600

    NEW YORK, Nov. 19, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Flex Ltd (NASD: FLEX) will replace Azenta Inc. (NASD: AZTA) in the S&P MidCap 400, and Azenta will replace Envestnet Inc. (NYSE:ENV) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, November 25. Bain Capital is acquiring Envestnet in a deal expected to be completed soon, pending final closing conditions. Azenta's market capitalization is no longer representative of the mid-cap market space.Concentra Group Holdings Inc. (NYSE:CON) will replace Myers Industries Inc. (NYSE:MYE) in the S&P SmallCap 600 effective prior to the openin

    11/19/24 5:56:00 PM ET
    $AZTA
    $CON
    $ENV
    Industrial Machinery/Components
    Technology
    Medical Specialities
    Health Care

    $CON
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Concentra Group Holdings Parent Inc.

    SC 13G - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)

    12/9/24 6:02:26 AM ET
    $CON
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Concentra Group Holdings Parent Inc.

    SC 13G - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)

    12/6/24 4:32:57 PM ET
    $CON
    Medical Specialities
    Health Care

    SEC Form SC 13D filed by Concentra Group Holdings Parent Inc.

    SC 13D - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)

    12/3/24 4:21:17 PM ET
    $CON
    Medical Specialities
    Health Care